Drug
Azelastine Mometazone
Azelastine Mometazone: highest development phase Phase 3, developed by Sandoz. 1 trial record tracked on RxWires.
- Highest phase
- Phase 3
- Developer
- Sandoz
Trials
| Drug | Phase | Indication |
|---|---|---|
| Azelastine + Mometazone, nasal spray NCT05590598 | Phase 3 | Seasonal Allergic Rhinitis |
Latest
No recent events.
Follow Azelastine Mometazone on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.